Trials / Completed
CompletedNCT01302145
Drug to Drug Interaction Study With ASP1941 and Metformin
A Double-blind, Randomized, Placebo-controlled, Parallel Design Study, in Patients With Type 2 Diabetes Mellitus, to Investigate the Safety, Pharmacokinetics and Pharmacodynamics Interactions of Multiple Oral Doses of ASP1941 and Metformin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A study to investigate the effect on safety, pharmacokinetics and pharmacodynamics when ASP1941 is administered as add-on therapy to metformin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | Tablet |
| DRUG | Metformin | Tablet |
| DRUG | Placebo | Tablet |
Timeline
- Start date
- 2009-02-25
- Primary completion
- 2009-12-09
- Completion
- 2009-12-09
- First posted
- 2011-02-23
- Last updated
- 2017-07-28
Locations
5 sites across 4 countries: Hungary, Netherlands, Poland, Slovakia
Source: ClinicalTrials.gov record NCT01302145. Inclusion in this directory is not an endorsement.